Written By |
Cancer cases and deaths among men in Africa predicted to rise by over 150%.
Search
Cancer cases in men are projected to rise by 84% by 2050, with deaths from the disease expected to nearly double, according to a global study using data from 185 nations. The analysis predicts that 19 million cancer cases will be diagnosed in men by 2050, up from 10 million in 2022, with deaths soaring from 5 million to over 10 million—a 93% increase.
While older men are expected to account for most of these fatalities due to an aging population, there is also a concerning rise in cancer deaths among younger men. The study, led by the University of Queensland, highlights the higher rates of cancer and related deaths in men compared to women, driven by factors such as lower participation in cancer prevention, underuse of screening, higher exposure to risk factors like smoking and drinking, and biological differences.
Non-melanoma skin cancer is expected to see the largest increase in cases, with diagnoses rising by nearly 122% globally. Mesothelioma and bladder cancer are also predicted to more than double. For cancer deaths, prostate cancer is projected to see the most significant growth, with a 136% increase in fatalities. Lung cancer will continue to have the highest death toll, with over 2 million deaths expected by 2050.
Experts warn that without immediate action, these trends will worsen, particularly in low and medium-income countries with limited cancer services. The study underscores the need for national and international collaboration to improve cancer outcomes and reverse the anticipated rise in cancer burden.
Data also shows regional disparities, with cancer cases and deaths among men in Africa predicted to rise by over 150%. In Europe, cancer cases in men are expected to grow by 40%, with deaths increasing by 50% by 2050.
The study's findings emphasize the urgent need for improved cancer care, particularly in poorer nations, to mitigate the predicted surge in cases and deaths.
